Cargando…

SRC-like adaptor protein negatively regulates Wnt signaling in intrahepatic cholangiocarcinoma

Currently, the molecular mechanisms underlying intrahepatic cholangiocarcinoma (IHCC) are poorly understood. In the present study, the focus was primarily on SRC-like adaptor protein (SLAP), an adaptor protein, which is aberrantly expressed in various cancer types. To the best of our knowledge, the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Yong, He, Xinxin, Wei, Yangnian, Liu, Ling, Wang, Wen, Li, Nianfeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2019
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6365946/ https://www.ncbi.nlm.nih.gov/pubmed/30854048 http://dx.doi.org/10.3892/ol.2019.9901

Ejemplares similares

MiR-381 functions as a tumor suppressor in colorectal cancer by targeting Twist1
por: He, Xinxin, et al.
Publicado: (2016)

Src-like Adaptor Protein (Slap) Is a Negative Regulator of T Cell Receptor Signaling
por: Sosinowski, Tomasz, et al.
Publicado: (2000)

Src-like adaptor protein 2 (SLAP2) binds to and inhibits FLT3 signaling
por: Moharram, Sausan A., et al.
Publicado: (2016)

The Emerging and Diverse Roles of Src-Like Adaptor Proteins in Health and Disease
por: Marton, Nikolett, et al.
Publicado: (2015)

Underexpression of LKB1 tumor suppressor is associated with enhanced Wnt signaling and malignant characteristics of human intrahepatic cholangiocarcinoma
por: Wang, Jinghan, et al.
Publicado: (2015)

Mucin 1 promotes tumor progression through activating WNT/β-catenin signaling pathway in intrahepatic cholangiocarcinoma
por: Song, Fei, et al.
Publicado: (2021)

SRC-like adaptor protein 2 (SLAP2) is a negative regulator of KIT-D816V-mediated oncogenic transformation
por: Rupar, Kaja, et al.
Publicado: (2018)

Epigenetic deregulation of MLF1 drives intrahepatic cholangiocarcinoma progression through EGFR/AKT and Wnt/β-catenin signaling
por: Tang, Zengwei, et al.
Publicado: (2023)

Metastatic Intrahepatic Cholangiocarcinoma Presenting as an Achalasia-like Syndrome
por: Gomes, Catarina, et al.
Publicado: (2021)

Case Report: Primary lymphoepithelioma-like intrahepatic cholangiocarcinoma
por: Liu, Fei, et al.
Publicado: (2023)

Adaptor protein XB130 regulates the aggressiveness of cholangiocarcinoma
por: Poosekeaw, Pirawan, et al.
Publicado: (2021)

Intrahepatic Sarcomatoid Cholangiocarcinoma
por: Malhotra, Shalini, et al.
Publicado: (2010)

Asbestos and Intrahepatic Cholangiocarcinoma
por: Brandi, Giovanni, et al.
Publicado: (2020)

Management of Intrahepatic Cholangiocarcinoma
por: Kodali, Sudha, et al.
Publicado: (2021)

Regulation of natural cytotoxicity by the adaptor SAP and the Src-related kinase Fyn
por: Bloch-Queyrat, Coralie, et al.
Publicado: (2005)

Blockade of CXCL12/CXCR4 signaling inhibits intrahepatic cholangiocarcinoma progression and metastasis via inactivation of canonical Wnt pathway
por: Zhao, Shengqiang, et al.
Publicado: (2014)

The MR Imaging of Primary Intrahepatic Lymphoepithelioma-like Cholangiocarcinoma: A Diagnostic Challenge
por: Liu, Yangyang, et al.
Publicado: (2023)

Programmed death-ligand 1 is upregulated in intrahepatic lymphoepithelioma-like cholangiocarcinoma
por: Wang, Lei, et al.
Publicado: (2016)

The construction of intrahepatic cholangiocarcinoma model in zebrafish
por: Wang, Jing, et al.
Publicado: (2017)

Neoadjuvant and Adjuvant Therapy in Intrahepatic Cholangiocarcinoma
por: Chen, Xing, et al.
Publicado: (2022)

Endocytic Adaptor Protein Tollip Inhibits Canonical Wnt Signaling
por: Toruń, Anna, et al.
Publicado: (2015)

Src-Like Adaptor Protein (SLAP) Binds to the Receptor Tyrosine Kinase Flt3 and Modulates Receptor Stability and Downstream Signaling
por: Kazi, Julhash U., et al.
Publicado: (2012)

VEGFR2 induces c-Src signaling and vascular permeability in vivo via the adaptor protein TSAd
por: Sun, Zuyue, et al.
Publicado: (2012)

Two Varieties of Intrahepatic Cholangiocarcinoma
por: Nagorney, David M.
Publicado: (1994)

Intrahepatic Cholangiocarcinoma with Sarcomatous Changes
por: Inoue, Yoshiyuki, et al.
Publicado: (2012)

Serum Markers of Intrahepatic Cholangiocarcinoma
por: Malaguarnera, Giulia, et al.
Publicado: (2013)

Intrahepatic cholangiocarcinoma: current perspectives
por: Buettner, Stefan, et al.
Publicado: (2017)

Intratumoral heterogeneity of intrahepatic cholangiocarcinoma
por: Walter, Dirk, et al.
Publicado: (2017)

Molecular heterogeneity in intrahepatic cholangiocarcinoma
por: Ahn, Keun Soo, et al.
Publicado: (2020)

Recurrent Intrahepatic Cholangiocarcinoma – Review
por: Bekki, Yuki, et al.
Publicado: (2021)

Stereotactic radiotherapy for intrahepatic cholangiocarcinoma
por: Borakati, Aditya, et al.
Publicado: (2022)

Surgical Aspects of Intrahepatic Cholangiocarcinoma
por: Kupietzky, Amram, et al.
Publicado: (2022)

Locoregional Therapy for Intrahepatic Cholangiocarcinoma
por: Owen, Mackenzie, et al.
Publicado: (2023)

Negative Impact of Preoperative Platelet-Lymphocyte Ratio on Outcome After Hepatic Resection for Intrahepatic Cholangiocarcinoma
por: Chen, Qing, et al.
Publicado: (2015)

Is Lymphadenectomy Reasonable for Elderly Intrahepatic Cholangiocarcinoma Patients?
por: Lin, Qianyi, et al.
Publicado: (2023)

Apatinib inhibits VEGF signaling and promotes apoptosis in intrahepatic cholangiocarcinoma
por: Peng, Hong, et al.
Publicado: (2016)

A Case of Clonorchiasis with Focal Intrahepatic Duct Dilatation Mimicking an Intrahepatic Cholangiocarcinoma
por: Kim, Bong Gap, et al.
Publicado: (2011)

The diagnostic and prognostic value of UBE2T in intrahepatic cholangiocarcinoma
por: Yu, Hua, et al.
Publicado: (2020)

Ultrasonographic findings of intrahepatic lymphoepithelioma-like cholangiocarcinoma associated with Epstein–Barr virus: Two cases report
por: Ling, Wenwu, et al.
Publicado: (2019)

Alterations of gut mycobiota profiles in intrahepatic cholangiocarcinoma
por: Zhang, Lilong, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_nccaug1b4npjgj6ik99j15smuu